Medscape23y
Comparison of Salmeterol/Fluticasone Propionate Combination With Budesonide in Patients With Mild-to-Moderate Asthma
Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...
MedPage Today1mon
Early Intratracheal Budesonide Didn't Improve Outcomes for Preterm Infants
Opens in a new tab or window In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of bronchopulmonary dysplasia (BPD), a ...
East Boston7d
With Respiratory Season Arrival, DPH Reminds Patients and Providers of Alternatives to Discontinued Asthma Medication
The fall and winter season typically brings an increase in asthma exacerbations in Massachusetts. During this time, circulating respiratory illnesses, such as flu, RSV, and COVID increase, can ...
Medscape23y
Comparison of Salmeterol/Fluticasone Propionate Combination With Budesonide in Patients With Mild-to-Moderate Asthma
Mean percentage predicted morning (a) and evening (b) peak expiratory flow rate (PEF) during 12 weeks of study treatment with a salmeterol/fluticasone propionate (FP) combination or budesonide in ...